MAM
Monaco Asset Management’s Heron Therapeutics HRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.24M | Buy |
1,080,000
+120,000
| +13% | +$248K | 0.39% | 29 |
|
|
2025
Q1 | $2.11M | Sell |
960,000
-252,743
| -21% | -$556K | 0.43% | 22 |
|
|
2024
Q4 | $1.86M | Sell |
1,212,743
-465,674
| -28% | -$712K | 0.27% | 32 |
|
|
2024
Q3 | $3.34M | Buy |
1,678,417
+165,253
| +11% | +$329K | 0.48% | 25 |
|
|
2024
Q2 | $5.3M | Sell |
1,513,164
-300,000
| -17% | -$1.05M | 0.84% | 13 |
|
|
2024
Q1 | $5.02M | Sell |
1,813,164
-413,311
| -19% | -$1.14M | 1.5% | 14 |
|
|
2023
Q4 | $3.79M | Buy |
2,226,475
+1,529,567
| +219% | +$2.6M | 1.11% | 24 |
|
|
2023
Q3 | $718K | Buy |
696,908
+291,908
| +72% | +$301K | 0.21% | 47 |
|
|
2023
Q2 | $470K | Buy |
+405,000
| New | +$470K | 0.13% | 47 |
|